XSX7 📈 Xtrackers Stoxx Europe 600 - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2581375156 • Europe Large-Cap Blend Equity
XSX7: Stocks, European, Equities, Index, Funds
‣ Company URL: http://www.dws.lu ‣ Domicile: Luxemburg ‣ Index Name: Morningstar DM Eur TME NR EUR
Additional Sources for XSX7 ETF
XSX7 ETF Overview
| Market Cap in USD | 3,110m |
| Category | Europe Large-Cap Blend Equity |
| IPO / Inception | 2023-03-08 |
XSX7 ETF Ratings
| Growth 5y | 62.8% |
| Fundamental | - |
| Dividend | 42.0% |
| Rel. Strength Industry | 164 |
| Analysts | - |
| Fair Price Momentum | 72.79 EUR |
| Fair Price DCF | - |
XSX7 Dividends
| Dividend Yield 12m | 3.34% |
| Yield on Cost 5y | 4.05% |
| Annual Growth 5y | 24.36% |
| Payout Consistency | 100.0% |
XSX7 Growth Ratios
| Growth Correlation 3m | -44.9% |
| Growth Correlation 12m | 69.2% |
| Growth Correlation 5y | 87.2% |
| CAGR 5y | 11.38% |
| CAGR/Mean DD 5y | 6.04 |
| Sharpe Ratio 12m | 0.45 |
| Alpha | -10.64 |
| Beta | 0.66 |
| Volatility | 13.60% |
| Current Volume | 1.7k |
| Average Volume 20d | 2.8k |
What is the price of XSX7 stocks?
As of December 27, 2024, the stock is trading at EUR 77.61 with a total of 1,718 shares traded.
Over the past week, the price has changed by -0.72%, over one month by -0.61%, over three months by -4.18% and over the past year by +7.97%.
As of December 27, 2024, the stock is trading at EUR 77.61 with a total of 1,718 shares traded.
Over the past week, the price has changed by -0.72%, over one month by -0.61%, over three months by -4.18% and over the past year by +7.97%.
Is Xtrackers Stoxx Europe 600 a good stock to buy?
Yes. Based on ValueRay Analyses, Xtrackers Stoxx Europe 600 (XETRA:XSX7) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 62.82 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XSX7 as of December 2024 is 72.79. This means that XSX7 is currently overvalued and has a potential downside of -6.21%.
Yes. Based on ValueRay Analyses, Xtrackers Stoxx Europe 600 (XETRA:XSX7) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 62.82 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XSX7 as of December 2024 is 72.79. This means that XSX7 is currently overvalued and has a potential downside of -6.21%.
Is XSX7 a buy, sell or hold?
Xtrackers Stoxx Europe 600 has no consensus analysts rating.
Xtrackers Stoxx Europe 600 has no consensus analysts rating.
What are the forecast for XSX7 stock price target?
According to ValueRays Forecast Model, XSX7 Xtrackers Stoxx Europe 600 will be worth about 80.1 in December 2025. The stock is currently trading at 77.61. This means that the stock has a potential upside of +3.17%.
According to ValueRays Forecast Model, XSX7 Xtrackers Stoxx Europe 600 will be worth about 80.1 in December 2025. The stock is currently trading at 77.61. This means that the stock has a potential upside of +3.17%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 80.1 | 3.2% |